Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its binding ability in a functional ELISA. When Recombinant Cynomolgus Monkey 4-1BB/TNFRSF9/CD137 Fc Chimera is immobilized at 0.05 µg/mL (100 µL/well), Recombinant Human 4-1BB Ligand/TNFSF9 (Catalog # ) binds with an ED 50 of 0.25-1.25 ng/mL.
Source
Human embryonic kidney cell, HEK293-derived
Cynomolgus Monkey 4-1BB/TNFRSF9
(Leu24-Gln186)
Accession # XP_005544945IEGRMD Human IgG1
(Pro100-Lys330)N-terminus C-terminus Accession #
N-terminal Sequence
AnalysisLeu24
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
44 kDa
SDS-PAGE
56-66 kDa, reducing conditions
9324-4B |
| |
Formulation Lyophilized from a 0.2 μm filtered solution in PBS. | ||
Reconstitution Reconstitute at 500 μg/mL in PBS. | ||
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. | ||
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Data Images
Bioactivity
| When Recombinant Cynomolgus Monkey 4‑1BB/TNFRSF9Fc Chimera is coated at 0.05 μg/mL, 100 μL/well, Recombinant Human 4-1BB Ligand/TNFSF9 (Catalog # ) binds with an ED50 of 0.25-1.25 ng/mL. |
Background: 4-1BB/TNFRSF9/CD137
4-1BB, also known as CD137 and TNFRSF9, is an approximately 30 kDa transmembrane glycoprotein in the TNF receptor superfamily. 4-1BB functions in the development and activation of multiple immune cells (1). Mature human 4-1BB consists of a 163 amino acid (aa) extracellular domain (ECD) with four TNFR cysteine‑rich repeats, a 27 aa transmembrane segment, and a 42 aa cytoplasmic domain (2, 3). Within the ECD, cynomolgus 4-1BB shares 95%, 57%, and 57% aa sequence identity with human, mouse, and rat 4-1BB, respectively. 4-1BB is expressed as a disulfide-linked homodimer on various populations of activated T cell including CD4 +, CD8 +, memory CD8 +, NKT, and regulatory T cells (4-7) as well as on myeloid and mast cell progenitors, dendritic cells, mast cells, and bacterially infected osteoblasts (8-11). It binds with high affinity to the transmembrane 4-1BB Ligand/TNFSF9 which is expressed on antigen presenting cells and myeloid progenitor cells (3, 8). This interaction co-stimulates the proliferation, activation, and/or survival of the 4-1BB expressing cell (3-7). It can also enhance the activation-induced cell death of repetitively stimulated T cells (3). Mice lacking 4-1BB show augmented T cell activation, perhaps due to its absence on regulatory T cells (12).
4-1BB can associate with OX40 on activated T cells, forming a complex that responds to either ligand and inhibits Treg and CD8 + T cell proliferation (13). Reverse signaling through 4-1BB Ligand inhibits the development of dendritic cells, B cells, and osteoclasts (8, 11) but supports mature dendritic cell survival and co‑stimulates the proliferation and activation of mast cells (9, 10). 4-1BB activation enhances CD8 + T cell and NK cell mediated anti-tumor immunity (14). It also contributes to the development of inflammation in high fat diet-induced metabolic syndrome (15). Soluble forms of 4-1BB and 4-1BB Ligand circulate at elevated levels in the serum of rheumatoid arthritis and hematologic cancer patients, respectively (16, 17).
References:
Wang, C. et al. (2009) Immunol. Rev. 229:192.
Schwarz, H. et al. (1993) Gene 134:295.
Alderson, M.R. et al. (1994) Eur. J. Immunol. 24:2219.
Wen, T. et al. (2002) J. Immunol. 168:4897.
Pulle, G. et al. (2006) J. Immunol. 176:2739.
Zheng, G. et al. (2004) J. Immunol. 173:2428.
Kim, D. et al. (2008) J. Immunol. 180:2062.
Lee, S. et al. (2008) Nat. Immunol.9:917.
Choi, B.K. et al. (2009) J. Immunol. 182:4107.
Nishimoto, H. et al. (2005) Blood 106:4241.
Saito, K. et al. (2004) J. Biol. Chem. 279:13555.
Lee, S. et al. (2005) J. Immunol. 174:6803.
Ma, B.Y. et al. (2005) Blood 106:2002.
Choi, B.K. et al. (2010) J. Immunol. 185:1404.
Kim, C. et al. (2011) Diabetes 60:3159.
Michel, J. et al. (1998) Eur. J. Immunol. 28:290.
Salih, H.R. et al. (2001) J. Immunol. 167:4059.
Entrez Gene IDs:
3604 (Human); 21942 (Mouse); 500590 (Rat); 102127961 (Cynomolgus Monkey)
Alternate Names:
4-1BB ligand receptor; 41BB; 4-1BB; CD137 antigen; CD137; CD137MGC2172; CDw137; FLJ43501; ILA; ILAhomolog of mouse 4-1BB; induced by lymphocyte activation (ILA); interleukin-activated receptor, homolog of mouse Ly63; receptor protein 4-1BB; T cell antigen ILA; T-cell antigen 4-1BB homolog; T-cell antigen ILA; TNFRSF9; tumor necrosis factor receptor superfamily member 9; tumor necrosis factor receptor superfamily, member 9
